Aurobindo Pharma Limited (AUROPHARMA)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
523.1
-15.45(-2.87%)

Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, over the counter drugs, and dietary supplements, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

Pricing Updates

TODAY'S HIGH

544

TODAY'S LOW

514.1

52 WEEK HIGH

1043.1

52 WEEK LOW

514.1

Major Holders

% of Shares Held by
All Insider

20.63%

% of Shares Held by
Institutions

26.15%

% of Float Held by
Institutions

32.94%

Number of Institutions
Holding Shares

169

Company Overview

MARKET CAP

30650.46 Cr.

ETERPRISE VALUE

31825.71 Cr.

NO. OF SHARES

58.59 Cr.

BOOK VALUE

399.491

DIV. YIELD

1.5%

DEBT

4766.19 Cr.

GROSS PROFIT

14584.85 Cr.

CASH

4497.19 Cr.

REVENUE

23647.61 Cr.

REVENUE/SHARE

403.631

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments-494.52 Cr.-187.68 Cr.-72.07 Cr.-67.76 Cr.
Change To Liabilities126.42 Cr.295.87 Cr.-499.28 Cr.396.69 Cr.
Total cashflows from Investing Activities598.69 Cr.-1567.64 Cr.-2902.59 Cr.-1926.59 Cr.
Net Borrowings-1082.44 Cr.-1632.36 Cr.2230.39 Cr.1202.22 Cr.
Total Cash from Financing Activities-1364.81 Cr.-1947.18 Cr.1919.06 Cr.864.15 Cr.
Other Liabilities-315.50 Cr.1195.14 Cr.-81.57 Cr.-38.98 Cr.
Total Assets019 Lakhs6 Lakhs23 Lakhs
Net Income5334.84 Cr.2845.14 Cr.2364.73 Cr.2423.17 Cr.
Change in Cash2583.09 Cr.871.24 Cr.665.64 Cr.891.91 Cr.
Effect of Exchange Rate-2.12 Cr.4.78 Cr.-1.80 Cr.-17 Lakhs
Total Cash from Operating Activities3328.92 Cr.4381.28 Cr.1650.97 Cr.1954.52 Cr.
Depreciation1055.39 Cr.963.21 Cr.667.72 Cr.554.87 Cr.
Other Cashflows from Investing Activities19.15 Cr.21.78 Cr.26.28 Cr.17.33 Cr.
Dividends Paid-234.31 Cr.-175.61 Cr.-146.02 Cr.-219.40 Cr.
Change to Inventory-1593.58 Cr.-526.98 Cr.-886.04 Cr.-1412.67 Cr.
Change to Account Receivables715.88 Cr.-656.12 Cr.-17.61 Cr.-68.16 Cr.
Other Cashflows from Financing Activities-48.06 Cr.-139.40 Cr.-165.37 Cr.-118.90 Cr.
Change to Net Income-1994.53 Cr.261.52 Cr.102.79 Cr.96.50 Cr.
Capital Expenditures-1437.94 Cr.-1382.75 Cr.-1425.68 Cr.-1322.94 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax7343.59 Cr.3743.04 Cr.3091.35 Cr.3241.18 Cr.
Minority Interest-88 Lakhs14 Lakhs1.59 Cr.1.82 Cr.
Net Income4453.57 Cr.3940.09 Cr.3311.83 Cr.3262.28 Cr.
Selling General Administrative3657.56 Cr.3333.29 Cr.2738.91 Cr.2241.38 Cr.
Gross Profit14584.85 Cr.13069.93 Cr.10595.85 Cr.9534.98 Cr.
Ebit4453.57 Cr.3940.09 Cr.3311.83 Cr.3262.28 Cr.
Operating Income4453.57 Cr.3940.09 Cr.3311.83 Cr.3262.28 Cr.
Other Operating Expenses5418.33 Cr.4829.84 Cr.3877.16 Cr.3473.35 Cr.
Interest Expense-59.57 Cr.-287 Cr.-250.72 Cr.-63.04 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense2009.77 Cr.899.35 Cr.726.85 Cr.818.27 Cr.
Total Revenue24774.62 Cr.23098.51 Cr.19563.55 Cr.16463.03 Cr.
Total Operating Expenses20321.05 Cr.19158.42 Cr.16251.72 Cr.13200.75 Cr.
Cost of Revenue10189.77 Cr.10028.58 Cr.8967.70 Cr.6928.05 Cr.
Total Other Income Expense Net2890.02 Cr.-197.05 Cr.-220.48 Cr.-21.10 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.5333.82 Cr.2843.69 Cr.2364.50 Cr.2422.91 Cr.
Net Income Applicable to Common Shares5334.83 Cr.2845.13 Cr.2364.73 Cr.2423.17 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets2554.60 Cr.2342.02 Cr.2271.45 Cr.1149.17 Cr.
Capital Surplus417.89 Cr.417.89 Cr.417.64 Cr.417.57 Cr.
Total Liabilities11925 Cr.12102.93 Cr.12561.99 Cr.9418.80 Cr.
Stock Holder Equity21929.87 Cr.16824.67 Cr.13890.78 Cr.11680.42 Cr.
Minority Interest-88 Lakhs14 Lakhs1.59 Cr.1.82 Cr.
Other Liabilities1316.10 Cr.1174.90 Cr.794.99 Cr.1625.54 Cr.
Total Assets33853.99 Cr.28927.74 Cr.26454.36 Cr.21101.04 Cr.
Common Stock58.59 Cr.58.59 Cr.58.59 Cr.58.59 Cr.
Retained Earnings20949.92 Cr.15855.56 Cr.13229.31 Cr.11024.92 Cr.
Other Liabilities825.26 Cr.453.88 Cr.361.47 Cr.301.71 Cr.
Good Will428.90 Cr.915.94 Cr.832.51 Cr.816.55 Cr.
Treasury Stock503.47 Cr.492.63 Cr.185.24 Cr.179.34 Cr.
Other Assets1300.26 Cr.585.98 Cr.622.32 Cr.509.55 Cr.
Cash5373.47 Cr.2763.71 Cr.1883.70 Cr.1214 Cr.
Current Liabilities10665.15 Cr.11384.64 Cr.12020.57 Cr.8665.89 Cr.
Long Term Asset Charges452.68 Cr.163.20 Cr.183.29 Cr.158.80 Cr.
Short Long Term Debt0139.67 Cr.213.60 Cr.287.39 Cr.
Other Stockholder Equity503.47 Cr.492.63 Cr.185.24 Cr.179.34 Cr.
Property Plant Equipment9315.51 Cr.8116.61 Cr.7035.59 Cr.6136.10 Cr.
Total Cur. Assets19823.51 Cr.16412.51 Cr.15332.30 Cr.12178.16 Cr.
Long Term Investments431.21 Cr.554.68 Cr.360.19 Cr.311.51 Cr.
Net Tangible Assets18946.37 Cr.13566.71 Cr.10786.82 Cr.9714.70 Cr.
Short Term Investments257.98 Cr.75.91 Cr.71.11 Cr.46.35 Cr.
Net Receivables4015.46 Cr.4818.19 Cr.5337.42 Cr.4312.18 Cr.
Long Term Debt168.40 Cr.0131.07 Cr.424.24 Cr.
Inventory9026.57 Cr.7699.87 Cr.7245.60 Cr.5858.41 Cr.
Accounts Payable2794.68 Cr.2576.06 Cr.2552.18 Cr.2372.90 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account